- Advertise
- Contact Us
- Contribute
- Editorial Info
- Terms and Conditions
- Privacy Policy
- Do Not Sell My Personal Information
- About Us
© 2022 MJH Life Sciences™ and Endocrinology Network. All rights reserved.
Endocrine Diseases
Study Assesses Brain Volume Differences in Girls with Central Precocious Puberty
November 01, 2021
An imaging study of girls with idiopathic CPP and matched controls suggests idiopathic CPP was associated with increased gray matter and white matter volumes in the cerebral area.
GnRHa Not Associated with Increased PCOS Risk in Patients with Endocrine Disorders
November 01, 2021
Using data from more than 50 women, investigators determined exposure to GnRHa treatment was not associated with an increased risk of developing PCOS in women with CPP treated with GnRHa.
Study Details Prevalence of Genetic Variants in Central Precocious Puberty
November 01, 2021
Results of a recent study provide insight into the prevalence of rare sequence variants among the MKRN3, DLK1, KISS1, and KISS1R genes in children with CPP.
Study Details Factors Negatively Impacting Time to Menarche in Central Precocious Puberty
November 01, 2021
Mount Sinai-led chart review provides insight into the influence of various factors on time to menarche among girls with central precocious puberty who received GnRHa treatment.
Risk Score Model Could Provide Inexpensive CPP Diagnosis Tool
November 01, 2021
A cross-sectional study has returned results that suggest a risk score model could help identify patients with central precocious puberty without the need for more expensive and invasive stimulation tests.
Influence of GnRHa on Long-Term Outcomes in Idiopathic Central Precocious Puberty
November 01, 2021
A systematic review and meta-analysis detail the effects of GnRHa therapy on final adult height, BMI, risk of PCOS, and more long-term outcomes among patients with idiopathic CPP.
Study Details "Widespread" Use of Endocrine-Disrupting Chemicals in North American Cosmetic Products
June 17, 2021
A study assessing levels of flourine in cosmetic products available in the US and Canada suggests many of these products could contain levels of chemicals that, over time, could cause harm.
Study Underlines Low Rates of Screening, Treatment for Primary Aldosteronism
April 01, 2021
A study from Canada is calling for additional attention to paid to the screening, diagnosis, and treatment of primary aldosteronism in adult patients.
Study Links Kidney Stones to Fracture Risk in Older Adults
March 03, 2021
An analysis of data from the Veterans Health Administration is providing insight into the apparent increase in risk of fracture or osteoporosis among older adults with kidney or ureteral stones.
Vitamin D Deficiency Not Linked to Type 1 Diabetes, Study Finds
March 02, 2021
Results of a two-sample Mendelian randomization analysis suggest vitamin D levels were unlikely to have a large effect on a person's risk for developing type 1 diabetes.